Which drugs does patent 6,191,148 protect, and when does it expire?
Patent 6,191,148 protects NEXIUM and PRILOSEC and is included in two NDAs. There has been one Paragraph IV challenge on Nexium.
Protection for NEXIUM has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-three patent family members in seventeen countries.